Albert Bourla, Pfizer CEO, joins CNBC's Angelica Peebles and 'Closing Bell Overtime' to talk the impact of tariffs, Pfizer's ...
As the second Trump administration settles in, the U.S.' top pharmaceutical trade group is drafting its ambitions for the ...
The meeting, which will include Pfizer CEO Albert Bourla as the newly named board of directors’ chair, will reportedly cover ...
A study by KFF found that one in four Republican parents now say they've skipped or delayed some childhood vaccines as of ...
The future of the CDC’s vaccine advisory committee seems uncertain: A scheduled February meeting for the ACIP, which advises ...
Latin Times on MSN21h
Pfizer Exec Booed During White House Appearance as Trump Calls Pharma Head 'Great Businessman'President Donald Trump's introduction of a Pfizer executive at the White House Wednesday was met with a roar of boos from the crowd.
The pharmaceutical industry’s biggest lobbying group is scheduled to meet with President Donald Trump on Thursday, according ...
Trump thanked Black voters for their support in the 2024 presidential election, saying he had 'more votes from black ...
As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives ...
Medpage Today on MSN2d
Health Execs Showered Trump With Millions; CDC Data Altered; Healthcare BankruptciesValentina Dabos, lead author of the tracker, said in a statement that the consequences of bankruptcies in healthcare "can be ...
Few CEOs know the double-edged nature of dealing with US President Donald Trump as viscerally as Pfizer’s Albert Bourla. In his first term, Trump championed the $18 billion Operation Warp Speed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback